Challenges and opportunities for applying quantum computers to drug design

ORAL

Abstract

The current limitations of classical computing methods in accurately describing quantum systems hinder the application of quantum chemistry to drug design. More precise computations could replace many labor-intensive experiments. Quantum computations could offer key insights into chemical systems, justifying high computational costs in an industrial setting. However, to significantly impact the pharmaceutical industry, quantum computers must address a broader set of problems, including those involving large protein structures. Significant advancements in hardware and quantum algorithms have reduced computational costs over the years, sparking optimism for the future use of quantum computing in quantum chemistry. However, harnessing the full potential of quantum computing in the pharmaceutical industry requires further improvements in hardware and novel algorithms. We will discuss these challenges and discuss several routes to achieve these goals and progress these challenges. Open research integrating academia and industry will help make quantum computing an essential tool for designing better drugs faster.

The current limitations of classical computing methods in accurately describing quantum systems hinder the application of quantum chemistry to drug design. More precise computations could replace many labor-intensive experiments, provided the computational cost is lower. Quantum computations could offer key insights into chemical systems, justifying high computational costs in an industrial setting. However, to significantly impact the pharmaceutical industry, quantum computers must address a broader set of problems, including those involving large protein structures. New methods that balance accuracy and time on quantum computers could be beneficial. Significant advancements in hardware and quantum algorithms have reduced computational costs over the years, sparking optimism for the future use of quantum computing in quantum chemistry. However, harnessing the full potential of quantum computing in the pharmaceutical industry requires further improvements in hardware and novel algorithms. We will discuss these challenges and explore several potential routes to achieve these goals.

Publication: Santagati, R. et al. Drug design on quantum computers. Arxiv (2023) doi:10.48550/arxiv.2301.04114 https://arxiv.org/abs/2301.04114

Presenters

  • Raffaele Santagati

    Boehringer-Ingelheim Quantum Lab, Boehringer Ingelheim

Authors

  • Raffaele Santagati

    Boehringer-Ingelheim Quantum Lab, Boehringer Ingelheim

  • Alán Aspuru-Guzik

    University of Toronto

  • Ryan Babbush

    Google LLC, Google, Google Quantum AI

  • Matthias Degroote

    Boehringer Ingelheim Pharm Inc

  • Leticia Gonzalez

    University of Vienna

  • Elica Kyoseva

    Boehringer-Ingelheim

  • Nikolaj Moll

    Boehringer Ingelheim

  • Markus Oppel

    University of Vienna

  • Robert M Parrish

    QC WARE, QC Ware Cooperation, QC Ware, QC Ware Corporation

  • Nicholas C Rubin

    Google, Google Quantum AI

  • Michael Streif

    Boehringer Ingelheim, Boehringer Ingelheim Quantum Lab

  • Christofer Tautermann

    Boehringer Ingelheim

  • Horst Weiss

    BASF

  • Horst Weiss

    BASF

  • Nathan Wiebe

    University of Toronto

  • Clemens Utschig-Utschig

    Boehringer Ingelheim